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Abstract: Transdermal microneedles have captured the attention of researchers in relation to a variety
of applications, and silicone-based moulds required to produce these systems are now widely
available and can be readily manufactured on the lab bench. There is however some concern over
the potential for accidental needlestick injuries and, as with any sharp hazard, the potential for
blood-borne pathogen transmission must be considered. This follows from recent governmental
concerns over the use of microneedle systems in dermabrasion. Despite the piercing nature of the
microneedle patch sharing many similarities with conventional hypodermic needles, there are notable
factors that mitigate the risk of contamination. A range of microneedle systems has been prepared
using micromoulding techniques, and their puncture capability assessed. A critical assessment of the
potential for accidental puncture and the control measures needed to ensure safe utilisation of the
patch systems is presented.
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1. Introduction
Microneedle patches are increasingly being advocated as a technological step change in drug
delivery applications and have been shown to offer a multitude of advantages over conventional
syringe-based approaches [1–3]. These microneedle (MN) systems typically comprise an array of
submillimetre-sized projections (50–900 µm) and, in contrast to conventional hypodermic injections,
are sufficiently small that the shallow penetration depth typically fails to trigger the dermal nerve
network [3,4]. The near painless puncture of the skin barrier allows the transport of a large variety
of drugs and vaccines to the underlying microcirculation, and the success of the general strategy has
seen a near exponential rise in publications [2]. As the development of MN patches has continued
apace, there has been a trickle-down availability of the technologies required to produce them with
silicone moulds, allowing rapid, low-cost production within conventional laboratory environments [1].
An example of a commercial mould and the resulting microneedle array is shown in Figure 1A.
The near invisibility of MN tips is often heralded as a major factor in countering needle phobia amongst
patients [5,6]; yet these same features can constitute a major issue with regard to their production
within the science/engineering laboratory. A comparison between a traditional hypodermic suture and
a microneedle tip is highlighted in Figure 1B, and it can be envisaged that the minute dimensions of
the MN patch and absence of an easily recognisable and intimidating sharp hazard have the potential
to create the false perception amongst students and researchers alike that such devices are benign and
could thus be dismissed as possessing little or no danger.
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Figure 1. (A) Micropoint™ 200 × 200 × 350 microneedle (MN) mould template and an example of the
resulting polymer cast MN patch. (B) Comparison of sharp hazards.
It is critical that the needle element is still recognised as constituting a sharp hazard as its primary
function is to puncture the skin barrier enabling access to the underlying tissue. While the intent may be
to deliver molecules, it must be noted that, in penetrating the skin, the microneedles will be in contact
with the subject’s tissue and microcirculation, with the subsequent extraction of the patch risking the
retrieval of blood and/or serous fluid [1–3]. As MN systems have become more readily accessible, there
is a need for considerable caution beyond conventional chemical risk assessments for those engaged in
their production. The latter is highlighted by a health notice issued by Public Health England in relation
to the use of dermabrasion microneedles where the possibility of needles transferring blood/serous
fluid containing blood borne pathogens (BBP) has been recognised [7]. It is noteworthy that the
microneedle rollers consist of needles with similar dimensions to those presently used in drug/vaccine
delivery patches. One of the core tenets of MN patch delivery is that the application within a clinical
setting is single use and thus minimises the issue of BBP transmission [1–3]. However, the production
of the MN systems within the laboratory creates a number of issues where the possibility of accidental
needlestick through careless handling or disposal of the MN devices is a clear hazard. The core aims
of the present investigation have been to investigate the attitudes of science/engineering students
towards the safety implications of handling microneedle arrays and to critically assess the ability of
control measures to mitigate the risk of accidental puncture.
2. Materials and Methods
2.1. Preparation of Microneedle Arrays
Materials: Polystyrene (PS) (avg. Mw 192,000), cellulose acetate phthalate, acetone (≥99.8%),
dichloromethane (DCM, ≥99.8%), and Parafilm M® were obtained from Sigma-Aldrich Company Ltd.
(Dorset, UK). Silicone MPatch™ microneedle templates were purchased from Micropoint Technologies
Pte Ltd. (CleanTech Loop, Singapore). Bodyguards Blue Nitrile™ gloves with an AQL rating of 1.5 and
a minimum typical break force of 9 N were obtained from BM Polyco Ltd. (Enfield, UK). All chemicals
purchased were of analytical grade and used without any further purification.
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Fabrication: Microneedle templates were cleaned prior to each use by way of sonication in DCM
for 300 s and allowed to dry at room temperature. Needle casting involved an initial aliquot of DCM
being introduced to a beaker, along with 200 mg of PS beads. A magnetic stirrer was then used to
produce a homogeneous PS/DCM mixture, after which the DCM was allowed to evaporate until
the desired viscosity was achieved. A small amount of DCM was first pipetted into the template to
displace any air present in the mould extremeties. Next, the PS suspension was pipetted into the
template, followed by sonication for 300 s to allow the PS suspension to fill the mould completely
and to remove any remaining air bubbles. The MNs were visually inspected following sonication and
further PS added, if required, to ensure the template was filled. Finally, the MNs were sonicated for a
further 300 s and any remaining DCM was allowed to evaporate at room temperature overnight.
Characterisation: The fabricated microneedle arrays were characterised by way of focused ion
beam scanning electron microscopy (JSM-6010PLUS/LV InTouchScope™ Analytical SEM, JEOL Ltd.,
Tokyo, Japan). Microneedles were sputtered under vacuum prior to scanning electronic microscopy
using an 80:20 Pd/Au target at 30 mA for 3 min (Emitech K500X Sputter Coater, Quorum Technologies
Ltd., East Sussex, UK). An accelerating voltage of 20 kV was used throughout. The resulting Pd
coating was applied principally to minimise charging effects during the electron imaging, and it was
typically applied post-puncture and had no influence on the mechanical integrity of the needles nor
their piercing properties.
2.2. Force Plate Measurements
In order to record force application, a force plate (FP-BTA, Vernier Software & Technology,
Beaverton, OR, USA) was employed in conjunction with a Go!Link® single-channel USB interface
and accompanying Logger Lite software from the same supplier. The force plate was positioned on
a lab bench, adjacent to a chair upon which 12 participants, both male and female, of ages 23–46,
were instructed to sit. Once comfortable, the participants were asked to rest on the force plate using
their forearm and then using the force plate for support, asked to transfer weight to their hand in
order to move from the chair to a standing position. A force-time measurement was recorded three
times per participant over a 10 s period in separate data files, with calibration performed prior to
each measurement. Finally, data was exported from Logger Lite to Excel 2016 (Microsoft, Redmond,
Washington, DC, USA) for statistical analysis and OriginPro 9.0 (OriginLab Corporation, Wellesley
Hill , MA, USA) for graphical analysis.
2.3. Glove Puncture Testing
The previously sputter-coated microneedle array was first attached to an aluminium stub using
hot melt adhesive. The assembly was wrapped in a section of nitrile glove, which was then placed into
and pulled through the SEM sample holder. Once positioned, the glove-wrapped stub was secured
into place using grub screws present in the sample holder, just tight enough to ensure that sagging of
the nitrile glove did not occur. A section of STAEDTLER Mars® plastic eraser (Nuremberg, Germany)
was then pressed upon the glove’s surface to induce microneedle penetration. This was repeated
until >90% of needles had visibly penetrated the nitrile glove barrier. Finally, the entire assembly was
sputter-coated once again to ensure electrical conductivity.
A pristine microneedle array was affixed to a custom machined compression platen using hot
melt adhesive, around which a glove was placed, stretched to size, and fixed using sellotape. A piece
of eraser cut to match the dimensions of the microneedle array was fixed onto an opposing platen
and aligned prior to compression testing. A custom compression profile was designed for use with a
single column universal testing system (Instron® 3344, Buckinghamshire, UK) paired with a 500 N
static load cell. Compression limits relating to the force plate scenarios mentioned previously were
implemented, i.e., 30 N for resting force, 100 N as an intermediary force, and 170 N for peak force
exertion upon standing. Glove samples were then transferred to an SEM sample holder and analysed
with an accelerating voltage of 5 kV.
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2.4. Survey of Sharp Hazard Perceptions
The perception of sharp hazards and control measures amongst first year undergraduate
completing a range of engineering-related programmes was assessed. The study data was
extracted from the results of a formative assessment scheduled as part of a compulsory Health
and Safety Induction within their Professional Studies module. A total of 88 students from
Mechanical Engineering, Mechatronic Engineering, Electrical and Electronic Engineering, Engineering
Management, Technology and Design, and Biomedical Engineering were required to participate in
an anonymous online quiz managed through BlackBoard Learn™ (Washington, DC, USA). The quiz
consisted of multiple choice and short answer questions and is available within the accompanying
supplementary information document. It was envisaged that the students would serve as a scientifically
and technically literate sample and, given that most would be entering a manufacturing environment,
their hazard perception was felt to be of particular relevance to the remit of the present study where
the focus is on safety within a production environment. The participation of students in the force
plate study and in the online quiz was approved by the Ulster University Faculty of Computing and
Engineering Ethics Filter Committee (Ref: 20170911 17.45 and 20170911 17.46)
3. Results
There are five principal classes of microneedle used for drug delivery applications: solid, drug
coated solid, hollow, dissolvable, and swellable [1–3,8–19]. The fabrication of solid MN arrays is
procedurally the simplest approach and can be constructed from a variety of conventional and
inexpensive polymers such as polystyrene, polycarbonate, and polymethylmethacrylate [8–12].
Such polymers enable the acquisition of mechanically robust arrays that can withstand repeated
handling by inexpert users, but the retention of the “sharp” aspect can inadvertently present a
needlestick hazard where such devices are carelessly discarded within the workspace. A typical
example of a mould-formed solid (non-dissolvable) polymer MN array cast from a solution of
polystyrene is shown in Figure 2 and highlights both the field of needles (A) and the sharp tip
that arises (B).
Figure 2. (A) Electron micrograph of a 10 × 10 MN array formed from the solution casting of
polystyrene. (B) Individual morphology of a 400 × 400 × 800 micron polystyrene MN.
Dissolving MN arrays are a relatively new approach and have many advantages over their
non-dissolvable analogues [15–17]. They can be produced using the same moulds and procedures used
for the fabrication of non-dissolvable systems. An example of a dissolvable MN array formed from the
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mould casting of cellulose acetate phthalate (CAP) is highlighted in Figure 3. The polymer is commonly
used as a pH responsive coating on oral medicines where its function is to protect the encased drug
from the rigors of the stomach [20]; the coating degrading in neutral/alkaline environments of the
intestine thereupon releasing the therapeutic agent. Similarly, the CAP polymer MN shown in Figure 3
rapidly dissolves when placed in a pH 8 buffer. In the dry state, the needles are mechanically robust
and rigid and, as seen in Figure 3A, possess a sharp tip with pronounced piercing capability. It is only
when the needles are subjected to an aqueous environment, particularly alkaline conditions, that the
needle swells and their mechanical strength is reduced through gradual dissolution (Figure 3B–D).
Figure 3. Progressive dissolution (A–D) of a 200 × 200 × 350 micron MN upon exposure to a pH 8
Britton Robinson buffer ((A) 0 min, (B) 5 min, (C) 10 min, (D) 15 min).
The dissolvable and swellable systems can be formed from a wide variety of polymer systems
with the dissolution rate controlled through the particular formulation employed [15–19]. The scope
and intricacies of the latter have been comprehensively reviewed elsewhere [1–3] and the compositions
exploited in this work are principally used as model systems. There are numerous advantages to
the adoption of dissolvable or swellable MNs and, in many respects, they represent the least risk in
terms of accidental needlestick and the transmission of BBPs. Upon penetration of the skin, they are
effectively self-disarming as their piercing capability is generally lost through the process of dissolution
or swelling [15–19].
Irrespective of type, the application of an MN patch is generally described as a pressing sensation
rather than a sharp or stabbing response [4], and it is of little surprise that this painless feature has
captured the interest of healthcare professionals and patients alike [3–6]. It has been estimated that
thumb pressure alone is sufficient to enable successful MN application in almost 90% of cases [21,22].
This facile application and pain-free administration therefore further compounds the risk where
accidental puncture could go relatively unnoticed, and it could be argued that the careless handling or
disposal of spent patches could be a greater hazard than a conventional hypodermic needle, which,
by its visibility, can immediately induce a degree of caution [5]. When the engineering students
were asked to identify the sharp hazards from a picture containing a hypodermic needle, a suture
needle, and a microneedle patch, 20% considered the latter to be a sharp hazard. It should be
recognised that these concerns go beyond the manufacturing environment, the focus of the present
study, and will be relevant to Home Health scenarios where careless disposal and accidental puncture
is equally possible. The latter will be significant for children and the elderly where it could be
anticipated that their hazard perception of MN patches is liable to be less than that demonstrated by
the engineering students—especially given that the students are engaged in science and engineering
degree programmes and should be more attuned to recent developments in technology.
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Most laboratories possess a heterogeneous population of roles, and, while those directly engaged
in MN research may be familiar with the hazards posed by the devices, there will inevitably be many
more who are not. It must be remembered that many of the students surveyed would not have come
across MN devices prior to the questionnaire, so their response could be considered representative
of those non-expert users and, as such, at risk of accidental injury through the reckless placement or
discarding of MN patches. While it can be readily accepted that unused or spent solid MN patches are
a hazard, there is a question over their ability to accidently puncture skin.
It is generally accepted that thumb pressure alone can facilitate MN puncture, but mechanical
applicators capable of delivering a pre-set force are also used as a means of counter any natural
variation in the former approach [23]. Accidental MN needlestick injuries will typically occur through
the physical depression of the skin onto an upturned MN patch left on a solid substrate/work
surface—most likely through the placement of a hand or arm on the latter. The level of risk is therefore
dependent on whether the forces exerted on the surface under normal activities are liable to be
sufficient to facilitate MN puncture. Two scenarios were investigated in which the subject is in a sitting
position and either casually resting their arm on the work surface (1) or using their hand/wrist to raise
their body from the seated to standing position (2). The force exerted on the work surface was determined
using force plate measurement and a typical force profile for each scenario is highlighted in Figure 4.
Figure 4. Variation in applied force as a consequence of resting an arm on a surface (1) and subsequently
using hand-wrist leverage to raise the subject from a seated to standing position (2).
The subject was initially in a seated position with no arms on the desk (force plate) surface. Upon
resting their arm on the plate—the applied force is increased and plateaus as the movement settles
into a natural resting state (Figure 4(1)). As the subject changes to a standing position, the force on the
plate increases dramatically as a consequence of hand-wrist leverage being applied to aid their rise
from the chair (Figure 4(2)). The magnitude of the various forces will clearly vary from one person to
another and this was found in practice where the mean forces for Scenarios 1 and 2 were found to be
45.1 ± 4.3 N and 171.4 ± 18.9 N, respectively, based on a sample of 12 volunteers. The force exerted on
the surface through casual placement of the arm alone is greater than that applied by a mechanical
applicator, but there are some important caveats to the interpretation of such data. The area in contact
with the plate in Scenario 1 will be relatively large, which will significantly dilute the effective pressure
applied and it is likely that normal clothing or lab coat would protect the arm and would remove any
possibility of skin penetration. The main risk rests in Scenario 2 where wrist leverage is employed.
There is a dramatic increase in force that, given the much reduced area of skin in contact with the
plate, will necessarily increase the effective pressure on any underlying MN patch. It is important to
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recognise that, in contrast to the arm, the hand/wrist will be the least protected and more susceptible
to MN puncture.
Latex or nitrile gloves are common features within most laboratories and form an intrinsic part of
the personal protection equipment and it could be envisaged that these would be the principal physical
barrier to preventing MN needlestick injuries in Scenario 2. The protective capability of conventional
nitrile and latex gloves (100 µm thick) towards puncture by MN patches was investigated. The MN
array was initially mounted in much the same way as would be expected for a discarded patch but, in
this case, a SEM stub simulated the work surface as outlined in Section 2.3. The needles were upturned
and a section of the glove stretched over the needles (Figure 5A). A small rubber square (serving as
the skin substitute) was then applied in a small-scale version of the process indicated in Scenario 2.
Subsequent analysis of the SEM stubs revealed that, if the needles are sufficiently long, penetration
of the glove is readily achieved. A typical example of the latter is shown in Figure 5B, where an MN
patch comprising polystyrene needles of 800 micron length (similar to those detailed in Figure 2) was
found to readily puncture the nitrile glove section and would be expected to retain their potential to
puncture the skin.
Figure 5. Penetration of 400 × 400 × 800 micron polystyrene MNs through conventional nitrile (A–E)
or latex (F) gloves (100 µm thick section). (A) SEM stub used for unregulated force puncture and (B) the
corresponding micrograph. (C–F) Influence of compression loading post-puncture micrographs of the
glove sections.
It must be noted that the force applied in this demonstration was unregulated. A more quantitative
assessment was conducted using custom compression profiles through which forces of 30 N, 100 N,
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and 170 N were applied to simulate the scenarios depicted in Figure 4. In this case, the glove section
was placed upon the needles rather than being stretched tightly across. After compression, the glove
section was removed and analysed using electron microscopy. The resulting micrographs for the nitrile
gloves at the various loadings are detailed in Figure 5C–E. A representative sample acquired for a latex
glove at 170 N loading is included in Figure 5F for comparison. It can be seen that compression at 30 N
failed to pierce the nitrile glove, whereas the 100 N and 170 N tests resulted in puncture for both nitrile
and latex. Puncture holes can be seen across the array and, although preliminary in nature, they serve
to corroborate the assertion that, in Scenario 2, leverage arising from a person’s wrist/palm when
attempting to rise could be a hazard.
Verbaan and coworkers found that the inherent elasticity of the epidermis typically resists
puncture; as a consequence, the penetration depth is generally markedly less than the height of
the actual microneedle [24]. They highlighted the disparity between the needle capability and potential
puncture dynamics with needles with lengths of 300, 550, 700, and 900 microns. The 300 micron needles
repeatedly failed to overcome the elastic deformation of the skin barrier and adequately puncture
human skin [24]. The dimensions of the needle highlighted in Figure 2B are 800 microns long and,
on the basis of Verbaan’s work, sufficiently large that, to unprotected skin, would indeed constitute a
puncture hazard [24]. There will be some clear variations from one person to another, and age-related
changes in skin will also influence the elasticity of the skin [25,26].
4. Discussion
The level of risk presented by an MN array is dependent on a number of factors, with the nature
of the needle structure, the potential BBP concentration, and the adoption and deployment of control
measures being among the more critical. Examples of more recent applications of MN are highlighted
in Table 1. In general, the moulds that are commercially available enable the pursuit of all bar the
hollow structures and the mode of action of the needle is largely dependent on the properties of the
polymer used in the casting process [1–3]. What is clear from Table 1 is that in most cases the needle
height/length is of a magnitude that is capable of puncturing conventional gloves. The consequences
of skin puncture are varied and, given the interplay of mechanical and chemical factors within the
needles and in relation to the skin, there is a need to consider the possible outcomes.
Table 1. Examples of MN systems.
Type Height/µm Material Purpose Ref.
Solid 130 to 1500 Stainless Steel Treatment of skin imperfections such asminor scars and wrinkles [8]
Solid 2802 Si/Ti/Pt Determining antimicrobial properties [9]
Solid 1200 Polystyrene Strength testing [10]
Coated 750 Stainless Steel, coated withlive-attenuated measles vaccine Measles Vaccine [11]
Coated 340 Nitrogen-incorporated ultrananocrystalline diamond titanium alloy Biosensing applications [12]
Hollow 200 Silicon Nicotine derivatives Influenza vaccine [13]
Hollow 300 Gold coated, hollow silicon Microneedles Drug delivery [14]
Dissolving 600 750 Carboxymethylcellulose Insulin/Sulforhodamine B Lidocaine [15]
Dissolving 1520 Chondroitin sulphate Heparin Erythropoietin [16]
Dissolving Various Sodium hyaluronate and hydrolysedcollagen/dextran/povidone Vaccine [17]
Swellable 700 Polystyrene/Poly Acrylic Acid Anti-scarring agents/antibiotics [18]
Swellable 600 Gantrez AN-139 and Polyethylene glycol, Drug delivery [19]
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The primary function of the MN is to breach the stratum corneum through the creation of
micron-sized channels [1–3], as indicated in Figure 6. It would be expected that the small dimensions
of the channels result in minimal damage to the skin and there have been many studies, which have
found no sustained erythema or irritation following the removal of the MN patch [27]. While the
principal intention of the channel is to enable the passage of drugs to the underlying tissue, it is
possible that the micro-channels could also serve as highways for the transport of bacteria. Under
clinical conditions, good practice would necessitate the preparation of the target area with the use of
alcohol/chlorhexidine wipes to remove adventitious species present upon the skin surface and thereby
substantially reduce the risk of infection. In the case of manufacturing laboratories, the assumption is
that any application to human skin occurs as a result of accident and that there will therefore be no
prior treatment. It has been shown that the potential for bacterial infection arising from microneedle
applications is considerably lower when compared with conventional injection systems [9,28], and,
under non-occlusive conditions, the microchannels would be expected to heal within 2 h of the initial
puncture [29]. The situation becomes more ambiguous where there is a failure in the dissolution
or removal of a dissolvable/swellable microneedle such that partially dissolved needle fragments
continue to bridge the skin barrier [1].
Figure 6. Cross-section schematic of the skin interface emphasising the effect of needle length on
penetration depth.
The potential for breakage of solid MNs, especially those composed of a non-degradable
material/polymer, is also a concern where shear forces, particularly in relation to needles with a
high aspect ratio, can result in fragmentation [30]. It is important to acknowledge that in a significant
number of publications relating to MN, the focus is on the mechanism and performance with far
weaker exploration of the biocompatibility of the materials. Where fragmentation is concerned, it is
possible to expect that small particles will be removed through the normal turnover of the epidermal
layers (typically 4 weeks) [31], but there have been reports of granulomas resulting from silicon and
glass fragments [32,33]. The latter can be countered through the use of biodegradable materials some
of which are highlighted in Table 1.
The most significant hazard relates to the possible transmission of a blood-borne pathogen as
indicated in the health warning issued by Public Health England [7]. There is a wealth of literature
on the typical contamination risks associated with these viruses within healthcare contexts where
needlestick injuries are common [34,35], but the abundance of statistics has no direct translation when
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considering risk within science/engineering/manufacturing laboratories where there is no routine
application to patients. The risks cannot be negated on that basis, however, and could be exacerbated
in some aspects in terms of discarded patches where, in contrast to healthcare sectors, there can be an
inadequate perception of the risk. There are a number of factors that influence the potential risk of
BBP transmission—the depth of penetration, the concentration of virus, the nature of the needle (solid
or hollow), and the presence of a glove (single or double) [36–39]. The stratum corneum is generally
regarded as being of the order of 10–20 microns, with the epidermal layer some 100–150 microns [25,26].
While skin deformation upon puncture will generally prevent complete insertion of the microneedle
array, it is clear from Table 1 that many of the MNs would have the capability of reaching the dermis
and directly accessing the microcirculation as indicated in Figure 6.
It has been shown that the risk associated with the transmission of a BBP through a solid needle
(typically a suture needle) is estimated to be tenfold less than a hollow bore with the disparity in
risk being attributed to the smaller volume of blood being transported in the former and hence a
reduction in the viral load [36,37]. It may be possible to equate an MN with a suture needle, but it
is also necessary to make note of the much shallower penetration depth that is permissible through
their application. This is highlighted in Figure 6 where increasing the length of the needle can result in
deeper penetration with access to the dermis layer increasing the potential for retrieval of blood.
There is clearly a significant difference between conventional hollow bore needles and MN arrays
where the dimensions of the former and the dynamics of movement induce greater risk of needlestick.
Nevertheless, MNs are designed to puncture skin and thus, it can be envisaged that a glove would
present similar challenges. While it is generally regarded within the healthcare sector that gloves
cannot prevent these injuries, it was clear from the studies here that the ability of an MN array to
puncture a glove is dependent on needle length.
The protection offered by gloves to minimise exposure of skin to chemicals and solvents within a
science laboratory is unquestionable, but it is clear from Figure 5 that they do not offer unequivocal
resistance to MN penetration. While it is widely accepted that the presence of a glove cannot prevent
penetration, they can possess an intrinsic cleaning action that can serve to minimise the transmission
of a BBP [36–39], as indicated in the schematic in Figure 7. It has been shown that, mechanistically,
the elasticity of the glove exhibits a “wiping- like” action on the tip of the needle not only as it
penetrates through the glove but also as it leaves. Studies employing radiolabeled blood (3H or 125I)
have been used to assess the efficacy of gloves (single and double) at removing contamination under
simulated needlestick events (hollow bore and suture) [36,37]. It has been estimated that a single glove
layer (irrespective of type) can remove between 50 and 86% of blood [36–38]. Krikorian and coworkers
demonstrated that the amount of transmitted blood is directly dependent on both internal needle
diameter and penetration depth with the speed of puncture, the angle of insertion, and the tension
experienced by a given part of the glove found to have little effect on the volume transferred [38].
Closer inspection of the electron micrograph detailed in Figure 4 reveals that the elasticity of the
nitrile film and the minute dimensions of the needle tip results in the polymer deforming around
the MN structure. The direct constrictive/frictional contact of the needle with the film is evident
and should therefore facilitate a physical cleansing action. In cases of deep puncture involving either
hollow bore or suture needle, there were no additional gains in puncture protection with double
gloving [40,41], but that may not be true in the case of MN arrays. The presence of a glove will certainly
reduce the degree to which a needle will puncture, but their influence is potentially greater in the
context of MNs where the length of the needles is greatly reduced.
The MN array, as mentioned previously, must overcome the elasticity of the glove and the stratum
corneum before reaching the tissue. It is important to remember that, unlike the hollow bore puncture,
the MN array is limited by the baseplate of the array in how far the needles can travel and therefore
the height, or in this case the length, of the needle becomes critical. As the probability of infection after
percutaneous injury depends on the volume and viral titer of blood transferred [42], it is clear that
minimising MN height, combined with the presence of gloves, could dramatically reduce potential risk.
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Figure 7. Influence of glove on the removal of biofluids upon initial penetration of a clean MN (I→II)
and upon accidental puncture by a previously contaminated patch (III→IV).
5. Conclusions
MN technologies have grown in prominence in recent years as their efficacy across a spectrum of
therapeutic applications has been demonstrated. The ability to manufacture relatively sophisticated
designs through low-cost, commercially available, micro-moulding techniques has enabled once
high-end research to be conducted in conventional laboratories. While there are a multitude of benefits
to increasing accessibility, it is clear that there is a need for considerable caution in the workspaces in
which the microneedle patches are produced and characterised. Most concerns regarding needlestick
injuries related to healthcare workers involved in patient contact, but the possibility of accidental
injury arising from the careless handling or disposal of microneedle patches is often overlooked.
The possibility of blood contamination and transmission needs to be recognised as a hazard, and while
the actual risk may be low in comparison to a clinical setting, it cannot be negated where there is a
general lab environment with personnel of varying expertise. It was clear from the student survey
that the hazard perception on first encountering a microneedle patches is compromised, failing to
recognise the device as a sharps hazard, so there is considerable need for greater cautionary education
and increased vigilance. Reductions in needle height could be employed to enhance safety, but it
must be recognised that some applications demand greater skin penetration, so a blanket restriction is
generally impractical. Compliance in the wearing of gloves and improved education are likely to be
more effective options that would enable these innovative technologies to be safely pursued.
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